» Articles » PMID: 12389625

Sickle Cell Anemia and Hematological Neoplasias

Overview
Journal Leuk Lymphoma
Specialties Hematology
Oncology
Date 2002 Oct 23
PMID 12389625
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Sickle cell disease (SCD) is a congenital hemolytic anemia with various clinical findings. In some cases hematological neoplasias and some solid tumors may accompany this disease but these have rarely been reported. Here we report five cases with SCD and accompanying hematological neoplasias including lymphoblastic lymphoma, multiple myeloma and hairy cell leukemia in four cases with sickle cell trait and one case of Hodgkin' disease in sickle cell anemia. All of the cases except one had no previously diagnosed congenital hemolytic anemia and/or family history. Peripheral blood findings suggestive for an underlying hemolytic anemia were the first step and the most important initial lead in the detection of SCD. Severe musculoskeletal signs during the first presentation was seen in the lymphoma case, residual renal dysfunction after remission of multiple myeloma, and areas of infarction in the spleen in CT scans in the patient with sickle cell anemia were the most interesting findings in these cases. A standard therapeutic approach without any additional toxicity was relevant in all cases. Detailed clinical presentation and outcome of these five cases are documented here and the literature has been reviewed.

Citing Articles

Sickle cell disease and acute leukemia: one case report and an extensive review.

Cannas G, Poutrel S, Heiblig M, Labussiere H, Larcher M, Thomas X Ann Hematol. 2023; 102(7):1657-1667.

PMID: 37269388 PMC: 10239223. DOI: 10.1007/s00277-023-05294-3.


Sickle Cell Disease in Early Infancy: A Case Report.

Muzazu S, Chirwa M, Khatanga-Chihana S, Munyinda M, Simuyandi M Pediatric Health Med Ther. 2022; 13:377-383.

PMID: 36536766 PMC: 9759007. DOI: 10.2147/PHMT.S388147.


Therapy Selection for Hodgkin Lymphoma in Sickle Cell Disease: balancing risks and benefits.

Fraley C, McKinney C, Nuss R, Franklin A Blood Adv. 2022; 7(10):2042-2046.

PMID: 36459497 PMC: 10188625. DOI: 10.1182/bloodadvances.2022008245.


Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature.

Zerdan M, Diacovo M, Chaulagain C Am J Case Rep. 2021; 22:e933470.

PMID: 34963677 PMC: 8721961. DOI: 10.12659/AJCR.933470.


Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the U.S.

Barbetta A, Goldbeck C, Lim A, Martin S, Kahn J, Sheikh M HPB (Oxford). 2021; 24(2):234-243.

PMID: 34294525 PMC: 8733051. DOI: 10.1016/j.hpb.2021.06.420.